The high cost of India’s private health-care boom

Why in the News

The Parliamentary Standing Committee on Health and Family Welfare’s 176th Report has found that the average cost of hospitalisation is ₹50,508 in a private facility against ₹6,631 in a government facility, and that out-of-pocket childbirth expenditure is ₹7,630 in private facilities against ₹2,299 in public ones. The Committee has made 368 recommendations, including standardised package rates, mandatory pre-treatment cost estimates, a proposal to cap basic room tariffs in metropolitan private hospitals at the average tariff of nearby three-star hotels, and a review of foreign direct investment (FDI) rules governing the acquisition and management of existing hospitals. The article argues this exposes a contradiction at the heart of India’s health policy: the country wants more private and foreign capital in health care, particularly in Tier-2, Tier-3 and rural areas, even as it moves to restrict the same capital’s ability to acquire existing hospitals.

What contradiction does the Committee’s report expose?

1. Wanting more capital and restricting it at once: The Committee wants India to attract more private and foreign investment in health care, especially in under-served Tier-2, Tier-3 and rural areas, while simultaneously asking the government to review FDI rules on the acquisition and management of existing hospitals.
2. Cross-subsidy expectation on corporate hospitals: Among its recommendations, large corporate hospitals earning from medical tourism, foreign patients and high-net-worth individuals are expected to cross-subsidise poorer Indians and reserve beds for Ayushman Bharat-Pradhan Mantri Jan Arogya Yojana (AB-PMJAY) beneficiaries at regulated rates.
3. The case for continued investment: Hospitals require substantial capital, for land, equipment, intensive care units, digital systems, laboratories and trained personnel, and public hospitals cannot currently meet all demand for secondary and tertiary care, so foreign investors and private-equity funds fill a genuine capacity gap; excessively restrictive or unpredictable regulation risks pushing that investment elsewhere.

How does information asymmetry drive up private health-care costs?

1. The patient cannot independently verify need: A patient rarely decides independently whether an MRI is required, whether admission should continue for two more days, or whether a procedure is necessary, because the provider knows more than the patient, the condition economists call information asymmetry.
2. Financial incentives shape volume, not just price: When financial incentives become too strong, they can influence not just the price of care but how much care is delivered in the first place.
3. Institutional incentives compound the effect: Corporate hospital groups competing for well-known specialists, sophisticated technology and premium infrastructure build a high-cost ecosystem; revenue targets, procedure-linked incentives, and higher occupancy or revenue-per-bed expectations can gradually influence institutional behaviour even where most doctors act in patients’ interests.
4. The resulting medicalisation: Lab investigations may detect abnormalities that would never have caused harm, more screening can lead to unnecessary follow-up tests, and a patient manageable as an outpatient may be admitted; Caesarean sections, angioplasties, intensive-care admissions, diagnostic packages and long medicine lists need to be read within this incentive structure, not only as individual clinical decisions.

What should an FDI review in hospitals actually test?

1. New capacity versus acquired capacity: Whether an investment creates new beds or simply acquires existing ones.
2. Competition versus concentration: Whether it improves competition or leads to market concentration.
3. Under-served areas versus metro saturation: Whether it enters an under-served district or adds another high-end facility in a metro that already has one.
4. Enforceable public-interest conditions: Where an investor receives concessional land, tax benefits or other public support, whether there are enforceable obligations tied to affordable beds or participation in public insurance schemes.

Why can’t a hotel-tariff-linked room cap fix hospital pricing?

1. A hospital room is not a hotel room: A hospital room includes nursing, infection-control and emergency support that a hotel room does not, so tying its tariff to a nearby three-star hotel’s rate is easy to understand but does not capture what the charge covers.
2. Capping one component shifts cost elsewhere: If one component of the bill is capped, hospitals may raise charges on other components, leaving the total bill largely unaffected.
3. A relevant precedent, with a caveat: India’s experience with coronary stent price regulation showed that government intervention can reduce excessive mark-ups, but hospital care is more complex than a single device, since what matters is the total cost of an episode, not one component.
4. The alternative on the table: Diagnosis-Related Groups (DRG), a patient-classification system that pays a fixed, predetermined amount for an inpatient stay based on the diagnosis and procedures involved, rather than reimbursing each service separately, alongside package rates, transparent cost estimates, billing standards and audit mechanisms.

Challenges to price capping and FDI review as the fix

1. Regulation cannot substitute for public capacity: India cannot regulate its way out of weak public health care; if government hospitals stay overcrowded, understaffed or hard to access, citizens will keep depending heavily on private providers regardless of price rules. Eg. OECD countries’ experience shows a strong public health system that offers a credible alternative is itself one of the most effective forms of regulation. Fix. Strengthen primary health care so disease is prevented, detected and treated early, so public hospitals become a genuine option rather than a last resort.
2. Insurance design can reinforce the wrong incentive: An insurance system that pays for volume of procedures, rather than appropriate care, reproduces the same incentive problem privately funded care already has. Fix. Redesign AB-PMJAY and similar insurance systems to reward appropriate, outcome-linked care rather than higher procedure volumes, backed by clinical audits and evidence-based treatment protocols.

Conclusion

Price caps and an FDI review are reasonable starting points, but the Committee’s own recommendations expose a deeper contradiction between wanting more private and foreign capital in health care and restricting the same capital’s ability to acquire hospitals. The article’s central argument is that the real fix does not lie only in capping prices, but in building a public health system credible enough to counterbalance the incentive structure that private investment creates; the next milestone is whether the government acts on the Committee’s recommendations, including the proposed FDI review.

Back2Basics: Parliamentary Standing Committee on Health and Family Welfare

1. It is a Department-related Parliamentary Standing Committee, one of the panels through which Parliament examines the working of a ministry, here the Ministry of Health and Family Welfare, between sittings of the House.
2. Its reports, such as the 176th Report cited here, are recommendatory: the government must respond to them but is not bound to act on their recommendations.
3. Its membership is drawn from both Houses of Parliament, giving it cross-party composition distinct from a ministry-appointed expert panel.

Matching Previous Year Question

“[2024, GS2, 15 marks] In a crucial domain like the public healthcare system, the Indian State should play a vital role to contain the adverse impact of marketisation of the system. Suggest some measures through which the State can enhance the reach of public healthcare at the grassroots level.”